N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism

Journal of Virology

Volumn 75, Issue 13, 2001, Pages 5998-6006

  Ogert, R A ^a   Lee, M K ^a   Ross, W ^a   Buckler White, A ^a   Martin, M A ^a   Cho, M W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; MUTANT PROTEIN;

ARTICLE; CELL FUSION; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; VACCINIA; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION;

BASE SEQUENCE; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRUS REPLICATION;

EID: 0034974149     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.13.5998-6006.2001     Document Type: Article

References (55)

1. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity
2. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization
3. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains
4. The block te HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s)
5. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism
6. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages
7. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4
8. Infection of chimpanzee peripheral blood mononuclear cells by human immunodeficiency virus type 1 requires cooperative interaction between multiple variable regions of gp120
9. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells
10. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
11. The V3 domain of the HIV-i gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
12. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates
13. Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing
14. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity
15. Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)
16. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research
17. Model for intracellular folding of the human immunodeficiency virus type 1 gp120
18. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
19. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
20. Selective extraction of polyoma DNA from infected mouse cell cultures
21. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
22. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
23. DH12 isolate
24. Higher western blot immunoreactivity of glycoprotein 120 from R5 HIV type 1 isolates compared with X4 and X4R5 isolates
25. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1
26. Chemokine receptors: Keys to AIDS pathogenesis?
27. The N-linked glycan of the V3 region of H1V-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant
28. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies
29. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1
30. Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4
31. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
32. Co-receptors for HIV-1 entry
33. HIV glycosylation: What does it portend?
34. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion
35. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
36. Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity
37. + T cells depends critically on basic amino acid residues in the V3 domain of envelope glycoprotein 120
38. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1
39. The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity
40. + cells expressing the rat homolog of CXCR-4 (fusin)
41. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
42. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop
43. Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1
44. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo
45. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1
46. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate
47. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
48. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates
49. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
50. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine
51. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120
52. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes
53. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing
54. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity
55. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera